ライフサイエンスコーパス: coronary angiography

1 was first manifestation of CAV diagnosed by coronary angiography.

2 Forty-nine patients were randomized to early coronary angiography.

3 k in a large cohort of patients referred for coronary angiography.

4 in patients with ASA sensitivity undergoing coronary angiography.

5 AR were measured in 3278 patients undergoing coronary angiography.

6 the PA and the LMCA and underwent selective coronary angiography.

7 ation, 50 received ECLS, and all 55 received coronary angiography.

8 ) in the studied patients who underwent MSCT coronary angiography.

9 nts with stable angina referred for invasive coronary angiography.

10 atinine 1.5-3 mg/dL) who were candidates for coronary angiography.

11 line serum TMAO and long-term survival after coronary angiography.

12 heart failure undergoing elective diagnostic coronary angiography.

13 rm mortality in patients with CKD undergoing coronary angiography.

14 on computed tomography (SPECT), and invasive coronary angiography.

15 in a separate CKD cohort (n=220) undergoing coronary angiography.

16 onfirmed at coronary CTA and at conventional coronary angiography.

17 HCA, 143688 (35.2%) were selected to undergo coronary angiography.

18 ing the frequency of nonobstructive invasive coronary angiography.

19 ca and enrolling 968 patients presenting for coronary angiography.

20 infusions of acetylcholine during diagnostic coronary angiography.

21 both cardiac magnetic resonance imaging and coronary angiography.

22 within 90 days than evaluation with invasive coronary angiography.

23 s with an intermediate degree of stenosis in coronary angiography.

24 tice paradigms to guide referral to invasive coronary angiography.

25 coronary CTA were referred for conventional coronary angiography.

26 tely after randomization and prasugrel after coronary angiography.

27 red with <60%, as determined by quantitative coronary angiography.

28 h cases revealing significant stenoses at CT coronary angiography.

29 urrence or persistence of angina requiring a coronary angiography.

30 loped in 318 patients (8%) who had undergone coronary angiography.

31 ticularly for patients undergoing diagnostic coronary angiography.

32 Patients underwent DE-CMR followed by coronary angiography.

33 s with acute infarction who are referred for coronary angiography.

34 the form of increased radiation doses during coronary angiography.

35 ex (BMI) and physician radiation dose during coronary angiography.

36 r the bioresorbable scaffold by quantitative coronary angiography (1.15 mm vs 1.46 mm, p<0.0001) and

37 Of these, 17 141 (65%) underwent coronary angiography, 12 183 (46.2%) underwent percutane

38 s. 9.1%), aspirin (12.7% vs. 8.5%), invasive coronary angiography (14.7% vs. 10.1%), and percutaneous

39 0.11-0.29], DSE 24 [95% CI, 0.10-0.38], and coronary angiography 20 [95% CI, 0.08-0.32; P = 0.91]).

40 ssessed in 3827 patients who were undergoing coronary angiography, 250 who were undergoing cardiac su

41 AC-present group, was less likely to undergo coronary angiography (3.4% versus 10.2%, P<0.0001), have

42 e tests (28% versus 17%; P=0.0009), invasive coronary angiography (31% versus 20%; P=0.0009), and rev

43 Coronary angiography (314 [35.0%] vs 925 [60.8%]; P < .0

44 nary angiography (78.3% versus 81.4%), early coronary angiography (49.2% versus 54.1%), percutaneous

45 Furthermore, for diagnostic coronary angiography 5F instead of 4F introducer was use

46 2] years) were analyzed: 628 (35.6%) without coronary angiography, 615 (35.7%) with coronary angiogra

47 3% versus 35.7%), and received less-frequent coronary angiography (78.3% versus 81.4%), early coronar

48 ac positron emission tomography and invasive coronary angiography, 92 patients with single- or 2-vess

49 Even in patients with an IRA determined by coronary angiography, a different IRA or a noncoronary a

50 t reduction in the utilization of diagnostic coronary angiography, a nonreported but related procedur

51 ronary artery disease on subsequent invasive coronary angiography across CAC score strata (Agatston s

52 D, 23.8%]), number of patients with invasive coronary angiography after 12 months was 102 in the NICE

53 d in making decisions regarding the need for coronary angiography after CABG.

54 esulting ischemia by whole-heart fluorescent coronary angiography after optical organ clearing and by

55 Among 247 subjects undergoing coronary angiography after resuscitation from a cardiac

56 All subjects undergoing coronary angiography after resuscitation from a cardiac

57 The benefit of emergency coronary angiography after resuscitation from out-of-hos

58 nts (n=329, 43% women) referred for invasive coronary angiography after stress testing with myocardia

59 utive patients (n=329) referred for invasive coronary angiography after stress testing with myocardia

60 There was a trend toward more invasive coronary angiographies among patients undergoing coronar

61 oss-sectional analysis of the utilization of coronary angiography among patients presenting with out-

62 ed to improve patient selection for emergent coronary angiography among resuscitated patients.

63 (interquartile range, 4-9.1) years with 4710 coronary angiographies analyzed.

64 A total of 205 procedures (122 diagnostic coronary angiographies and 83 percutaneous coronary inte

65 ergoing TAVR, screening of CAD with invasive coronary angiography and ad hoc PCI during TAVR is feasi

66 ol subjects were identified from the Swedish Coronary Angiography and Angioplasty Register between 20

67 open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enroll

68 Data was used from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) on all pa

69 included from the nationwide SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

70 All patients were registered in the Swedish Coronary Angiography and Angioplasty Registry.

71 Conventional two-dimensional readout of CT coronary angiography and cardiac MRI resulted in eight o

72 (61+/-9 years, 52% women) were included via coronary angiography and computed tomography as part of

73 Later, coronary angiography and DE-CMR images were reviewed ind

74 After coronary angiography and echocardiography, all underwent

75 ndent core laboratory performed quantitative coronary angiography and evaluated all pressure tracings

76 508 patients (mean age, 62 y) who underwent coronary angiography and extensive clinical and radiogra

77 Consecutive patients who underwent CT coronary angiography and FFR assessment with one or more

78 ton emission computed tomography, as well as coronary angiography and fractional flow reserve measure

79 ents were 48 patients who underwent invasive coronary angiography and had no known coronary artery di

80 ents were 48 patients who underwent invasive coronary angiography and had no known coronary artery di

81 ll as efficacy at 1 month using quantitative coronary angiography and histomorphometry.

82 When the Society of Coronary Angiography and Intervention definition of peri

83 composite end point of death, MI (Society of Coronary Angiography and Intervention definition), ische

84 l artery is now the most frequent access for coronary angiography and intervention.

85 ETHODS AND Serial (baseline and 6-12 months) coronary angiography and intravascular ultrasound were p

86 tudy of the prospective Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Us

87 ry assessment by clinical stratification and coronary angiography and of coronary intervention on pro

88 andom cohort of patients that have undergone coronary angiography and oral examination.

89 AR preprocedurally in patients who underwent coronary angiography and patients who underwent cardiac

90 From 2000 to 2012, coronary angiography and PCI after VT/VF OHCA increased

91 nts: An observational analysis of the use of coronary angiography and PCI in 407974 patients hospital

92 s was used to assess factors associated with coronary angiography and PCI use.

93 The role of immediate coronary angiography and percutaneous coronary intervent

94 and Percutaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervent

95 increasing frequency as the access point for coronary angiography and percutaneous coronary intervent

96 ends, predictors, and outcomes of performing coronary angiography and percutaneous coronary intervent

97 cardial infarction who were about to undergo coronary angiography and percutaneous coronary intervent

98 o radial (4197) or femoral (4207) access for coronary angiography and percutaneous coronary intervent

99 ess issues were observed in 2.5% and 2.1% of coronary angiography and percutaneous coronary intervent

100 ored over transfemoral access for performing coronary angiography and percutaneous coronary intervent

101 ort further resuscitation efforts, including coronary angiography and percutaneous coronary intervent

102 Coronary angiography and percutaneous intervention rely

103 mly assigned to radial or femoral access for coronary angiography and percutaneous intervention, and

104 y, NIRS was performed in patients undergoing coronary angiography and possible percutaneous coronary

105 h an initial invasive strategy consisting of coronary angiography and revascularization (if appropria

106 Subsequent rates of coronary angiography and revascularization after stress

107 Significant heterogeneity for invasive coronary angiography and revascularization was noted, wh

108 Coronary angiography and revascularization were performe

109 especially those without STE, do not undergo coronary angiography and revascularization.

110 ss) with protocol-specified 1-year post-CABG coronary angiography and SAQ assessments were included (

111 s using all available information, including coronary angiography and serial levels of high-sensitivi

112 to evaluate the efficacy and safety of early coronary angiography and to determine the prevalence of

113 -82 years]; 52% male) underwent conventional coronary angiography and were compared with age- and sex

114 Cases of MI, which had undergone coronary angiography and were discharged alive between 2

115 low in the infarct-related artery at initial coronary angiography, and complete (>=70%) ST-segment re

116 nderwent cardiac magnetic resonance imaging, coronary angiography, and invasive hemodynamic assessmen

117 those tested, only 5.9% underwent subsequent coronary angiography, and only 3.1% underwent repeat rev

118 ECLS, coronary angiography, and percutaneous coronary interven

119 rterial extracorporeal membrane oxygenation, coronary angiography, and percutaneous coronary interven

120 ata, 12-lead ECG, 12-hour Holter recordings, coronary angiography, and serial plasma levels of high-s

121 years, presumably due to an increased use of coronary angiography, and the clinical availability and

122 oronary intervention included in the Swedish Coronary Angiography Angioplasty Registry (SCAAR) betwee

123 Significant CAD was defined by invasive coronary angiography as >50% stenosis of the left main s

124 ved the diagnostic performance of MPI, using coronary angiography as a reference standard.

125 Optimal diagnostic cut-offs for CAV, with coronary angiography as gold standard, were defined usin

126 ical outcome of patients with ACS undergoing coronary angiography, as compared with patients with sta

127 o had undergone computerised tomography (CT) coronary angiography at our institute were studied for m

128 Noninvasive tests are as good as coronary angiography at predicting future adverse cardio

129 th stress perfusion imaging and quantitative coronary angiography available, with extended survival e

130 of atherosclerotic CAD detected by elective coronary angiography between 2012 and 2014.

131 T) Program to analyze patients who underwent coronary angiography between January 1, 2009, and Septem

132 consecutive patients with ACS who underwent coronary angiography between July 2006 and March 2008 in

133 severity was quantified in each subject via coronary angiography by calculating a CAD score.

134 ated with the presence of CAV at the time of coronary angiography by using multivariate logistic regr

135 ulations on patients' radiation doses during coronary angiography (CA) and PCI and temporal trends ar

136 Coronary angiography (CA) is the basis of an invasive ma

137 Although invasive coronary angiography (CA) remains the gold standard for

138 gistry of Acute Coronary Events) score >140, coronary angiography (CAG) is recommended by European an

139 Identification of the IRA by coronary angiography can be challenging in patients with

140 with stable chest pain and planned invasive coronary angiography, care guided by CTA and selective F

141 cardiovascular patient-based Western Norway Coronary Angiography Cohort (WECAC; n = 4161).

142 AF and 7,159 unaffected individuals from two coronary angiography cohorts and a cohort comprising pat

143 ement in OHCA care, with particular focus on coronary angiography, coronary revascularization, and me

144 ents had on-site clinical reads and invasive coronary angiography correlations within 6 mo of MPI.

145 CSA during coronary angiography could effectively remove more than

146 ry angiography (QCA) but computed tomography coronary angiography could exclude significant CAD.

147 ients were subjected to CSA procedure during coronary angiography (CSA group), and 25 patients served

148 Computed tomography coronary angiography (cTCA) and stress cardiac magnetic

149 erosclerosis on baseline computed tomography coronary angiography (CTCA) performed for suspected coro

150 ulness of screening with computed tomography coronary angiography (CTCA), and assess the safety and e

151 imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based m

152 visual estimation (DSVE) and by quantitative coronary angiography (DSQCA) was compared with FFR.

153 ive management pathway initiated by invasive coronary angiography during their hospitalization and up

154 They underwent coronary angiography, endothelial function testing; meas

155 The color-coded display of FFR values during coronary angiography facilitates the integration of phys

156 FFR derived from routine coronary angiography (FFR(angio)) eliminates both of the

157 he long-term outcomes of patients undergoing coronary angiography for acute coronary syndrome (ACS) o

158 METHODS AND Adults who underwent coronary angiography for acute ST-segment-elevation and

159 al registry of real-life patients undergoing coronary angiography for clinically indicated reasons (n

160 ious clinical trials, does not support early coronary angiography for comatose survivors of cardiac a

161 To assess the diagnostic value of MDCT coronary angiography for evaluation of acute chest pain

162 The unadjusted rate of coronary angiography for patients presenting with out-of

163 Among women referred for coronary angiography for signs and symptoms of ischemia,

164 way B Vitamin Intervention Trial) undergoing coronary angiography for stable angina pectoris were stu

165 Patients undergoing coronary angiography for suspected coronary heart diseas

166 ion in patients who were undergoing elective coronary angiography for suspected stable angina pectori

167 successful targeted temperature management, coronary angiography, formal electrophysiology assessmen

168 cant coronary artery disease identified with coronary angiography from the ACTION Registry-GWTG (Get

169 Comparison to quantitative coronary angiography (>/=50%) yielded a prevalence of 65

170 Women referred for coronary angiography had a significantly lower burden of

171 ts with confirmed LMCA stenosis on selective coronary angiography had PCI.

172 Recently, a high-quality multislice CT coronary angiography has been advocated in the diagnosis

173 coronary artery disease and guide treatment, coronary angiography has many known limitations, particu

174 trials of routine versus selective invasive coronary angiography have high rates of crossover from c

175 a total of 14% of patients undergoing early coronary angiography having an acutely occluded culprit

176 h atrial fibrillation (AF) by using invasive coronary angiography (ICA) as the reference method and t

177 ardiac arrest patients referred to immediate coronary angiography (ICA) irrespective of their first p

178 Invasive coronary angiography (ICA) with measurement of fractiona

179 onin levels often routinely undergo invasive coronary angiography (ICA), but many do not have obstruc

180 thin 12 h) or standard (48 to 72 h) invasive coronary angiography (ICA).

181 d as >=50% stenosis by quantitative invasive coronary angiography (ICA).

182 timal medical therapy without catheter-based coronary angiography if coronary CT angiography found on

183 echocardiography followed by catheter-based coronary angiography if echocardiography induced mild or

184 ronary artery, and ended with catheter-based coronary angiography if stress imaging induced ischemia

185 from diagnosis codes and verified them using coronary angiography images, matching each case to 3 con

186 The IRA was not identifiable by coronary angiography in 37% of patients (n=42).

187 n the clinical profile and indication for CT coronary angiography in myocardial bridging were collect

188 Guidelines recommend emergency coronary angiography in patients with ST-segment elevati

189 The emergence of noninvasive coronary angiography in patients with suspected coronary

190 vations on ECG after OHCA, while the role of coronary angiography in patients without ST-segment elev

191 ascular care guidelines recommend performing coronary angiography in resuscitated patients after card

192 The use of invasive coronary angiography in stable ischemic heart disease (I

193 ant difference in the adjusted likelihood of coronary angiography in states with public reporting, th

194 lent myocardial infarction (MI) referred for coronary angiography in the CASABLANCA (Catheter Sampled

195 o early coronary angiography versus no early coronary angiography in this multicenter study.

196 plications of coronary thrombus, detected by coronary angiography, in a population recruited in all-c

197 Nonselected patients undergoing coronary angiography, in which at least 1 lesion was int

198 Use of coronary angiography increased from 27.2% in 2000 to 43.

199 a period of ten years in persons undergoing coronary angiography, independent of the natriuretic pep

200 nary access challenges in patients requiring coronary angiography/intervention post-TAVR.

201 rial, 45 (B1) and 56 patients (B2) underwent coronary angiography, intravascular ultrasound (IVUS), a

202 nt elevation acute coronary syndromes before coronary angiography is a common practice despite an inc

203 elevation acute coronary syndromes awaiting coronary angiography is associated with excess bleeding

204 dial infarction, it is unknown whether early coronary angiography is associated with improved surviva

205 oronary syndrome or when computed tomography coronary angiography is performed during evaluation of c

206 s, detection is often difficult and invasive coronary angiography is performed routinely.

207 d had evidence of coronary artery disease on coronary angiography managed with either percutaneous co

208 d chromatography in 1411 patients undergoing coronary angiography (mean age 63 years, male 66%).

209 y end point was protocol-defined unnecessary coronary angiography (normal fractional flow reserve >0.

210 hest pain with troponin elevation and normal coronary angiography) occurred in 15% of patients with D

211 Early coronary angiography (occurring within one calendar day

212 Figure 1b: Coronary angiography of the left anterior descending (LA

213 Figure 1a: Coronary angiography of the left anterior descending (LA

214 Figure 1d: Coronary angiography of the left anterior descending (LA

215 Figure 1c: Coronary angiography of the left anterior descending (LA

216 rson-years of follow-up underwent diagnostic coronary angiography, of whom 281 (40 ST-segment elevati

217 without signs of STEMI to undergo immediate coronary angiography or coronary angiography that was de

218 Ninety patients underwent transradial coronary angiography or intervention and were scanned wi

219 Patients undergoing coronary angiography or percutaneous coronary interventi

220 , 1.5 [1.1-2.1]), acute (<24 hours) and late coronary angiography (OR, 10 [5.3-22] and 3.8 [2.5-5.7])

221 was higher than that of CTA and quantitative coronary angiography (P=0.01 and P<0.001, respectively).

222 In coronary angiography patients without structural heart d

223 Conclusions and Relevance: Coronary angiography, PCI, and survival to discharge hav

224 in Outcomes and Measures: Temporal trends of coronary angiography, PCI, and survival to discharge in

225 Use of coronary angiography, percutaneous coronary intervention

226 erest included in-hospital mortality, use of coronary angiography, percutaneous coronary intervention

227 to the Northeast were less likely to receive coronary angiography, percutaneous coronary intervention

228 Compared with coronary angiography performed soon after recanalization

229 nting a case of critical hand ischemia after coronary angiography performed through radial access des

230 dobutamine stress echocardiography (DSE) or coronary angiography, performed during preoperative eval

231 ost-mortem CT (PMCT), enhanced with targeted coronary angiography (PMCTA), in adults to avoid invasiv

232 oc analyses, we assessed changes in invasive coronary angiography, preventive treatments, and clinica

233 ences of CCTA-assisted diagnosis on invasive coronary angiography, preventive treatments, and clinica

234 Among coronary angiography procedures, increasing patient BMI

235 Among 1119 coronary angiography procedures, significant increases i

236 osure data were collected during consecutive coronary angiography procedures.

237 (b) Coronary angiography projection after LAD stent placemen

238 (a) Initial coronary angiography projection.

239 In addition to coronary angiography, promising data has been recently r

240 ference standards were combined quantitative coronary angiography (QCA) and single-photon emission CT

241 CAD was defined by quantitative coronary angiography (QCA) but computed tomography coron

242 n stenosis severity measured by quantitative coronary angiography (QCA) on the benefit of complete re

243 fractional flow reserve >0.8 or quantitative coronary angiography [QCA] showing no percentage diamete

244 uced utilization of other stress modalities, coronary angiography, reduced smoking, and greater utili

245 ms of subsequent noninvasive tests, invasive coronary angiography, revascularization procedures, cumu

246 roach was used to evaluate the likelihood of coronary angiography, revascularization, and in-hospital

247 ed the effects of this exclusion on rates of coronary angiography, revascularization, and mortality a

248 If invasive coronary angiography revealed <50% stenosis in all major

249 Early coronary angiography revealed a culprit vessel in 47%, w

250 CT coronary angiography revealed positive coronary artery d

251 CT coronary angiography revealed significant stenoses in se

252 beta blockers (RR=0.96; 95% CI, 0.91-0.99), coronary angiography (RR=0.93; 95% CI, 0.86-0.99) and co

253 Conventional coronary angiography served as the standard of reference

254 METHODS AND When invasive coronary angiography showed CAD, the treatment strategy

255 revealed ST elevation during chest pain and coronary angiography showed coronary vasospasm, which le

256 In 83 patients (13.8%), coronary angiography showed severe CAD that was left unt

257 e to the pubis symphysis was performed after coronary angiography, subsequent interventional procedur

258 e to the pubis symphysis was performed after coronary angiography, subsequent interventional procedur

259 e to the pubis symphysis was performed after coronary angiography, subsequent interventional procedur

260 to undergo immediate coronary angiography or coronary angiography that was delayed until after neurol

261 of coronary artery disease detected on MDCT coronary angiography that were not mirrored by conventio

262 rospective registry of patients referred for coronary angiography, the goal of this study was to deve

263 e (FFR) is an invasive procedure used during coronary angiography to determine the functional signifi

264 cally stable symptomatic women who underwent coronary angiography to evaluate symptoms and signs of i

265 use of coronary physiology as an adjunct to coronary angiography to guide percutaneous coronary inte

266 ocol-based monitoring consisting of repeated coronary angiographies together with systematic assessme

267 ion to informed consent regulations to early coronary angiography versus no early coronary angiograph

268 The median time from randomization to coronary angiography was 4.5 h (interquartile ratio [IQR

269 PCI as compared with no coronary angiography was associated with a lower day-30

270 f 1312 propensity score-matched pairs, early coronary angiography was associated with higher odds of

271 caused by VF or pulseless VT, we found early coronary angiography was associated with higher odds of

272 Bleeding before coronary angiography was associated with longer hospital

273 Selective invasive coronary angiography was considered to be the gold stand

274 The diagnostic yield of invasive coronary angiography was highest in patients with CAC>40

275 Early coronary angiography was not associated with any signifi

276 pitalization (14.6% within 90 days), whereas coronary angiography was performed in 11.1% of patients

277 Intraprocedural coronary angiography was performed in 8 patients.

278 Coronary angiography was performed in a routine fashion

279 or diameter stenosis >/=80% on quantitative coronary angiography was used as reference standard to d

280 e less than 0.8, as measured during invasive coronary angiography, was the reference for defining sig

281 per-vessel obstructive stenosis by invasive coronary angiography were also compared.

282 R, coronary CT angiography, and quantitative coronary angiography were evaluated against those of inv

283 fifty patients undergoing transradial access coronary angiography were included in the study.

284 Patients undergoing coronary angiography were recruited into 2 cohorts (1, n

285 0 to 2018, 4622 diabetic patients undergoing coronary angiography were screened for inclusion.

286 Patients who underwent early coronary angiography were younger (59.9 versus 62.0 year

287 raphy by visual estimate and by quantitative coronary angiography when compared with FFR and evaluate

288 serve as an effective gatekeeper to invasive coronary angiography will depend, in part, on the adopti

289 levation myocardial infarction, and emergent coronary angiography with angioplasty and intravascular

290 levation myocardial infarction, and emergent coronary angiography with angioplasty and intravascular

291 f 155 patients with suspected CAD listed for coronary angiography with FFR were prospectively enrolle

292 d computed tomography compared with invasive coronary angiography with fractional flow reserve for th

293 y manifestation, with indications to undergo coronary angiography with intent to perform percutaneous

294 with a history of ASA sensitivity undergoing coronary angiography with intent to undergo percutaneous

295 ventions in the care pathways included early coronary angiography with or without percutaneous corona

296 nd 1768 ECGs of adult patients who underwent coronary angiography within 24 h from each ECG were used

297 We also analyzed a subgroup who underwent coronary angiography within 30 days after positive DSE.

298 population) and regardless of the timing of coronary angiography (within or after 24 h from enrollme

299 thout coronary angiography, 615 (35.7%) with coronary angiography without PCI, and 479 (27.8%) with b

300 ures undertaken during these admissions (ie, coronary angiography without percutaneous coronary inter